Guardant Health Inc (NASDAQ: GH) kicked off on Monday, up 8.24% from the previous trading day, before settling in for the closing price of $20.51. Over the past 52 weeks, GH has traded in a range of $15.81-$37.04.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 49.27%. While this was happening, its average annual earnings per share was recorded 23.98%. With a float of $117.72 million, this company’s outstanding shares have now reached $121.63 million.
Considering the fact that the conglomerate employs 1779 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 82.26%, operating margin of -79.43%, and the pretax margin is -76.15%.
Guardant Health Inc (GH) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of Guardant Health Inc is 4.31%, while institutional ownership is 97.38%. The most recent insider transaction that took place on Jun 04 ’24, was worth 2,787. In this transaction Director of this company sold 100 shares at a rate of $27.87, taking the stock ownership to the 4,621 shares. Before that another transaction happened on Mar 18 ’24, when Company’s Chief Information Officer bought 2,187 for $17.82, making the entire transaction worth $38,963. This insider now owns 12,722 shares in total.
Guardant Health Inc (GH) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported -0.73 earnings per share (EPS), higher than consensus estimate (set at -0.94) by 0.21. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.7 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 23.98% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.20% during the next five years compared to -8.88% drop over the previous five years of trading.
Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators
Take a look at Guardant Health Inc’s (GH) current performance indicators. Last quarter, stock had a quick ratio of 6.07. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.24.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.09, a number that is poised to hit -0.74 in the next quarter and is forecasted to reach -2.84 in one year’s time.
Technical Analysis of Guardant Health Inc (GH)
Compared to the last year’s volume of 2.05 million, its volume of 1.37 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 38.57%. Additionally, its Average True Range was 0.92.
During the past 100 days, Guardant Health Inc’s (GH) raw stochastic average was set at 12.19%, which indicates a significant decrease from 91.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 47.39% in the past 14 days, which was lower than the 55.85% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $23.67, while its 200-day Moving Average is $24.03. Nevertheless, the first resistance level for the watch stands at $22.78 in the near term. At $23.36, the stock is likely to face the second major resistance level. The third major resistance level sits at $24.35. If the price goes on to break the first support level at $21.22, it is likely to go to the next support level at $20.23. Now, if the price goes above the second support level, the third support stands at $19.65.
Guardant Health Inc (NASDAQ: GH) Key Stats
The company with the Market Capitalisation of 2.73 billion has total of 122,369K Shares Outstanding. Its annual sales at the moment are 563,950 K in contrast with the sum of -479,450 K annual income. Company’s last quarter sales were recorded 177,240 K and last quarter income was -102,630 K.
